DMC Investment from Queensland BDF

DMC Confirms $2,500,000 Investment from Queensland BDF​

Friday 22 May, 2020

Brisbane based De Motu Cordis Pty Ltd (DMC) is delighted to confirm receipt of a $2,500,000 investment from Queensland Business Development Fund (BDF).

DMC is an exciting medical technology start-up company commercially developing a family of medical device solutions for the delivery of active pharmaceutical ingredients in critical and emergency care situations.

“Queensland Treasury believe that supporting emerging companies through the $80 million BDF underpins the Government’s commitment to growing jobs and strengthening the State’s entrepreneurial ecosystem.

The BDF has a unique and highly successful funding model which stands out from the crowd. The Fund has been successful in growing the pool of angel and venture capital funding to support the growth of innovative businesses, which in turn creates high-value jobs and showcases Queensland in Australia and around the world”.

DMC further acknowledge the considerable role played by Nick Capell and The Queensland Investment Corporation (QIC) to facilitate this process, as we are now very well placed to deliver upon our upcoming key next stage development milestones.

Continue Reading DMC Investment from Queensland BDF

DMC Attends FAST Qld program in San Francisco

DMC attends second session of the FAST Queensland program in San Francisco​

Sunday 26 January, 2020

DMC were excited to attend the second session of the FAST Queensland program in San Francisco. 

This was a valuable experience to accelerate our path to market, and an honour to be one of the five companies to be awarded a position on the program, coordinated by Trade and Investment Queensland and California Life Sciences Institute.

You can read more about the award here.

2020-01 DMC SF Trip
Continue Reading DMC Attends FAST Qld program in San Francisco

Nothing is Impossible – TEDxUQ 2019

Nothing is Impossible - Prof John Fraser on his DMC Journey​

Saturday 10 August, 2019

As a medical disruptor and the founder of Australia’s largest clinical multi-disciplinary research group, Professor John Fraser believes that technology and innovative approaches will pave the road to a safer world for patients.

He is currently tackling the growing epidemic of cardiac arrest and life-threatening allergies through founding De Motu Cordis Pty Ltd (DMC). In his talk, John explores the future of cardiac arrest treatment by bringing the hospital to the patient, and delves into the mistakes he has made and lessons he has learned when translating research into reality.

Professor John Fraser is a medical disruptor, who founded Australia’s largest clinical multi-disciplinary research group, based in Australia’s largest cardiothoracic hospital, The Prince Charles Hospital. From half an office, and with no staff, he has built a team of more than 70 clinicians, engineers, scientists, and economists with global links – connected to all of the major cardiothoracic hospitals globally.

His strong interest in developing all things cardiovascular resulted in him co-founding BiVACOR™ – a total bionic heart – with Dr Daniel Timms its inventor. He has now moved on to tackling the growing epidemic of cardiac arrest and life-threatening allergy through founding De Motu Cordis Pty Ltd (DMC).

In his talk, John will discuss his mistakes made and lessons learned in how to move research into reality, where DMC is developing drug technology and a device to improve the delivery of critical care drugs to patients outside the hospital environment.

This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx

Continue Reading Nothing is Impossible – TEDxUQ 2019